Evidence map›Paper›PMID 38672073›Full record

ArticleBiomedicines2024

NMDA Receptor Antagonist Memantine Ameliorates Experimental Autoimmune Encephalomyelitis in Aged Rats.

Biljana Bufan, Ivana Ćuruvija, Veljko Blagojević, Jelica Grujić-Milanović, Ivana Prijić, Tatjana Radosavljević, Janko Samardžić, Milica Radosavljevic, Radmila Janković, Jasmina Djuretić

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Biljana BufanDepartment of Microbiology and Immunology, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-1861-5700
Ivana ĆuruvijaDepartment of Research and Development, Institute of Virology, Vaccines and Sera, Torlak, 11000 Belgrade, Serbia.ORCID 0000-0001-7009-3933
Veljko BlagojevićDepartment of Research and Development, Institute of Virology, Vaccines and Sera, Torlak, 11000 Belgrade, Serbia.ORCID 0000-0002-8491-9924
Jelica Grujić-MilanovićInstitute for Medical Research, National Institute of the Republic of Serbia, Department of Cardiovascular Research, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-8014-3121
Ivana PrijićDepartment of Research and Development, Institute of Virology, Vaccines and Sera, Torlak, 11000 Belgrade, Serbia.
Tatjana RadosavljevićInstitute of Pathological Physiology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-1701-3313
Janko SamardžićInstitute of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-8464-4924
Milica RadosavljevicInstitute of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0009-0004-4591-7143
Radmila JankovićInstitute of Pathology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-5733-9505
Jasmina DjuretićDepartment of Pathobiology, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-8457-4962
University of Belgrade · RSInstitute of Virology, Vaccines and Sera “Torlak” · RS

Funding

Ministry of Science, Technological Development and Innovation, Republic of Serbia 451-03-47/2023-01/200161; 451-03-47/2023-01/200177; 451-03-66/2024-03/ 200015; 451-03-66/2024-03/200110; 451-03-66/2024-03/200110
6 · The paper itself

Abstract

Aging is closely related to the main aspects of multiple sclerosis (MS). The average age of the MS population is increasing and the number of elderly MS patients is expected to increase. In addition to neurons,

Indexed as

agingEAEmemantinemultiple sclerosisNMDARs

Identifiers

PMID38672073
PMCPMC11047843
OpenAlexW4393140157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.